NYSE: REA

Rare Earths Americas, Inc.

CIK 0002095743 · SIC 1000 · Metal Mining

Small by assets Assets $102M as of Aug 30, 2026

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (P 10-Q) is open in full — no account needed.

8-K Filed Aug 25, 2026 · Period ending Aug 20, 2026

Summary not yet generated.

8-K Filed Aug 20, 2026 · Period ending Aug 19, 2026

Summary not yet generated.

Partner

Trade REA commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

10-Q Filed Aug 11, 2026 · Period ending Jun 30, 2026

Summary not yet generated.

8-K Filed Aug 6, 2026 · Period ending Jul 31, 2026

Summary not yet generated.

8-K Filed Jun 16, 2026 · Period ending Jun 15, 2026

Summary not yet generated.

10-Q Filed Jun 4, 2026 · Period ending Mar 31, 2026 Red flag

net income -$16.8M. Rare Earths Americas reports Q1 loss, discloses material control weaknesses

5 material changes detected. Sign up free to read the summary.

8-K Filed May 12, 2026 · Period ending May 7, 2026

Rare Earths Americas grants $1.98M in equity compensation to three executives

4 material changes detected. Sign up free to read the summary.

S-1/A Filed Apr 28, 2026 Red flag

Rare Earths Americas files for $50M IPO at $18/share, valuing company at $349M

5 material changes detected. Sign up free to read the summary.

Latest financial statements

From 10-Q filed Aug 11, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Condensed Consolidated Statements of Operations (Unaudited)

(in thousands of U.S. Dollars, except share and per share data)

Description Three months ended June 30, 2026 Three months ended June 30, 2025 Six months ended June 30, 2026 Six months ended June 30, 2025
Operating expenses:
Exploration and evaluation expenses 4,566 115 6,631 165
General and administrative expenses 8,174 269 10,890 518
Depreciation expense 36 2 59 3
Transaction costs 157 157
Total operating expenses 12,776 543 17,580 843
Operating loss (12,776) (543) (17,580) (843)
Other income (expenses):
Interest income 503 630
Interest expense (29) (58) (74) (59)
Foreign currency transaction gain/(loss) 1 (3)
Change in fair value of SAFE (1,216) (4,625)
Change in fair value of warrants 727 (7,919)
Total other (expenses) income (14) (58) (11,991) (59)
Loss before income taxes (12,790) (601) (29,571) (902)
Provision for income taxes
Net loss (12,790) (601) (29,571) (902)
Less: Net loss attributable to noncontrolling interest
Net loss attributable to Rare Earths Americas, Inc. (12,790) (601) (29,571) (902)
Net loss per common share, basic and diluted (0.70) (0.06) (1.78) (0.10)
Weighted average common shares outstanding, basic and diluted 18,186,556 9,375,000 16,585,168 9,375,000

Condensed Consolidated Balance Sheets (Unaudited)

(in thousands of U.S. Dollars, except share data)

Description June 30, 2026 December 31, 2025
ASSETS
Current assets
Cash and cash equivalents 10,099 22,841
Short-term investments 66,640
Prepaid expenses 1,201 216
Other current assets 72 53
Total current assets 78,012 23,110
Non-current assets
Property and equipment, net 739 390
Mineral interests (includes $2,275 and $2,275, respectively, related to consolidated VIEs) 23,421 23,327
Deferred offering costs 1,968
Other non-current assets 210 42
Total non-current assets 24,370 25,727
Total assets 102,382 48,837
LIABILITIES
Current liabilities
Accounts payable (includes $841 and $362, respectively, related to consolidated VIEs) 1,574 1,486
Accrued expenses (includes $267 and $22, respectively, related to consolidated VIEs) 736 1,211
Convertible related party loan 1,123
Other current liabilities (includes $133 and $34, respectively, related to consolidated VIEs) 143 36
Total current liabilities 2,453 3,856
Non-current liabilities
SAFE liability 11,715
Warrant liability 11,675 4,433
Other non-current liabilities (includes $64 and $20, respectively, related to consolidated VIEs) 968 370
Total non-current liabilities 12,643 16,518
Total liabilities 15,096 20,374
Commitments and contingencies (Note 12)
STOCKHOLDERS' EQUITY
Preferred stock, $0.0001 par value, 1,000,000 shares authorized, zero shares issued and outstanding as of June 30, 2026 and December 31, 2025
Common stock, $0.0001 par value, 500,000,000 shares authorized, 19,953,892 and 14,965,987 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively 2 1
Additional paid-in-capital 134,910 46,292
Accumulated other comprehensive loss (492) (267)
Accumulated deficit (49,409) (19,838)
Equity attributable to stockholders of the Company 85,011 26,188
Noncontrolling interest 2,275 2,275
Total stockholders' equity 87,286 28,463
Total liabilities and stockholders' equity 102,382 48,837

Condensed Consolidated Statements of Cash Flows (Unaudited)

(in thousands of U.S. Dollars)

Description Six months ended June 30, 2026 Six months ended June 30, 2025
Cash flows from operating activities:
Net loss (29,571) (902)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation expense 59 3
Loss on foreign currency transaction 3
Stock-based compensation expense 7,086
Provision for labor claims 15 13
Allocated expenses from parent 63
Change in fair value of warrants 7,919
Change in fair value of SAFE 4,625
Exploration option purchased with shares 362
Noncash interest expense 58
Changes in operating assets and liabilities:
Prepaid expenses (991) (126)
Other assets (181) 9
Accounts payable 442 (3)
Accrued expenses (240)
Accounts payable to related parties 1,219
Other liabilities 149 (20)
Net cash (used in) provided by operating activities (10,265) 256
Cash flows from investing activities:
Purchases of short-term investments (74,871)
Proceeds from sales of short-term investments 8,231
Purchases of property and equipment (414) (2)
Investment in mineral interests (94)
Net cash used in investing activities (67,148) (2)
Cash flows from financing activities:
Proceeds from initial public offering, net of underwriting discounts and commissions ($4,832) 64,197
Payments for taxes related to net share settlement of equity awards (162)
Payments of deferred offering costs (2,858) (206)
Warrant exercises 214
SAFE proceeds 3,365
Net cash provided by (used in) financing activities 64,756 (206)
Effect of exchange rates on cash and cash equivalents (85) (43)
Net decrease in cash and cash equivalents (12,742) 5
Cash and cash equivalents at beginning of period 22,841 6
Cash and cash equivalents at end of period 10,099 11
Supplemental non-cash information:
Non-cash contribution from REA Australia 63
Unpaid deferred offering costs 180
SAFE Liability conversion to common stock 19,705
Related party note conversion to common stock 1,322
Lease liabilities arising from obtaining right-of-use assets 134

Amounts as printed on the EDGAR/iXBRL face — (in thousands of U.S. Dollars, except share and per share data); (in thousands of U.S. Dollars, except share data); (in thousands of U.S. Dollars). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗